COM:HYLORIS
Hyloris Pharmaceuticals
- Stock
Last Close
5.80
22/11 16:35
Market Cap
327.60M
Beta: -
Volume Today
60.81K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -3.87M - | -5.47M 41.46% | -5.27M 3.57% | -7.14M 35.48% | -11.58M 62.06% | -10.77M 6.99% | -15.76M 46.35% | |
depreciation and amortization | 65K - | 88K 35.38% | 3.31M 3,656.82% | 581K 82.43% | 137K 76.42% | 196K 43.07% | 349K 78.06% | |
deferred income tax | -1.33M - | 1K - | 196K 19,500% | |||||
stock based compensation | 1.33M - | 485K - | 576K 18.76% | 560K 2.78% | ||||
change in working capital | 856K - | 13K 98.48% | -2.59M 20,015.38% | 31K 101.20% | -777K 2,606.45% | -3.38M 334.36% | 2.18M 164.59% | |
accounts receivables | 808K - | 81K 89.98% | -2.07M 2,653.09% | -2.26M 9.33% | -293K 87.04% | |||
inventory | ||||||||
accounts payables | -218K - | -1.40M 541.28% | 1.14M 181.40% | -468K 141.12% | 1.24M 364.10% | |||
other working capital | -3.18M - | 1.35M 142.40% | 153K 88.65% | -646K 522.22% | 1.24M 291.49% | |||
other non cash items | 1.33M - | -5K - | 1.48M 29,640.00% | 197K 86.66% | 235K 19.29% | 910K 287.23% | ||
net cash provided by operating activities | -1.62M - | -5.37M 232.18% | -4.56M 15.01% | -4.57M 0.18% | -11.25M 146.17% | -13.15M 16.92% | -12.32M 6.32% | |
investments in property plant and equipment | -2.80M - | -31K 98.89% | -1.23M 3,867.74% | -623K 49.35% | -1.06M 70.30% | -739K 30.35% | -723K 2.17% | |
acquisitions net | 62K - | 50K 19.35% | -1.27M - | |||||
purchases of investments | -10K - | -1.18M 11,680% | -500K 57.56% | |||||
sales maturities of investments | 2K - | 3K - | 216K - | |||||
other investing activites | -1K - | 218K - | 9.97M - | |||||
net cash used for investing activites | -2.74M - | 19K 100.69% | -1.23M 6,563.16% | -633K 48.45% | -3.08M 385.78% | -1.24M 59.71% | 9.25M 846.65% | |
debt repayment | -21K - | -43K 104.76% | -52K 20.93% | -8.10M 15,478.85% | -62K 99.23% | -7.38M 11,796.77% | -190K 97.42% | |
common stock issued | 12K - | 5.75M 47,816.67% | 59.25M - | 17.17M - | ||||
common stock repurchased | ||||||||
dividends paid | ||||||||
other financing activites | 4.41M - | 2.06M 53.30% | 3.36M 63.27% | 18.24M 442.98% | -1.96M - | 2K 100.10% | ||
net cash used provided by financing activities | 4.40M - | 7.76M 76.56% | 3.31M 57.40% | 69.40M 1,997.85% | -62K 100.09% | 7.84M 12,741.94% | -188K 102.40% | |
effect of forex changes on cash | 1K - | -10.00M - | ||||||
net change in cash | 47K - | 2.42M 5,040.43% | -2.48M 202.73% | 64.19M 2,686.38% | -14.39M 122.41% | -6.55M 54.44% | -13.26M 102.30% | |
cash at beginning of period | 224K - | 271K 20.98% | 2.69M 891.51% | 205K 92.37% | 64.40M 31,314.15% | 50.01M 22.34% | 43.46M 13.11% | |
cash at end of period | 271K - | 2.69M 891.51% | 205K 92.37% | 64.40M 31,314.15% | 50.01M 22.34% | 43.46M 13.11% | 30.20M 30.52% | |
operating cash flow | -1.62M - | -5.37M 232.18% | -4.56M 15.01% | -4.57M 0.18% | -11.25M 146.17% | -13.15M 16.92% | -12.32M 6.32% | |
capital expenditure | -2.80M - | -31K 98.89% | -1.23M 3,867.74% | -623K 49.35% | -1.06M 70.30% | -739K 30.35% | -723K 2.17% | |
free cash flow | -4.42M - | -5.40M 22.26% | -5.79M 7.28% | -5.19M 10.34% | -12.31M 137.07% | -13.89M 12.85% | -13.05M 6.10% |
All numbers in (except ratios and percentages)